Alanine aminotransferase, serum
Clinical Background:
ALT is an intracellular cytoplasmic enzyme. It is widely distributed throughout the body’s tissues, with the greatest amounts in liver and the kidneys. It is a key enzyme in gluconeogenesis. ALT pr...
ALT is an intracellular cytoplasmic enzyme. It is widely distributed throughout the body’s tissues, with the greatest amounts in liver and the kidneys. It is a key enzyme in gluconeogenesis. ALT present in the plasma is presumed to be derived from the normal turnover of tissue cells; increased quantities are found in tissue damage (particularly hepatic cell damage).
Test Details
-
Discipline:
Biochemistry
Biochemistry
-
Specimen Container Adult:
Serum-SST
Serum-SST
-
Specimen Container Paediatric:
Serum-Plain tube
Serum-Plain tube
-
Minimum Volume Adult:
1 mL blood
1 mL blood
-
Minimum Volume Paediatric:
0.5 mL blood
0.5 mL blood
-
Sample Stability:
Unseparated: 4 days.
Separated:
7 days at 4ºC
3 days at 15-25C
Unseparated: 4 days.
Separated:
7 days at 4ºC
3 days at 15-25C
-
Interpretation:
ALT is used to identify liver damage e.g. arising from liver cell
inflammation or necrosis, significant increases in its plasma
activity are rarely seen other than in liver disease. It may be mea...Read MoreALT is used to identify liver damage e.g. arising from liver cell
inflammation or necrosis, significant increases in its plasma
activity are rarely seen other than in liver disease. It may be measured
both in patients with clinical features suggestive of liver disease and in
patients at risk of developing liver disease.
This latter category includes individuals with:
• a high alcohol intake
• a history of known or possible exposure to hepatitis viruses
• obesity or diabetes
• a history of consumption of potentially hepatotoxic drugs
• a family history of liver disease.
ALT is measured as an index of liver damage for which it is
more specific than aspartate aminotransferase (AST). Values >20x the
upper limit of normal may occur with severe liver damage. Smaller
increments (usually <5xULN) may occur in cholestasis, due to secondary
damage to hepatocytes.
In established liver disease, a falling ALT value usually reflects
decreasing cell damage, but may occasionally be a consequence of such
massive destruction that, with clearance of the enzyme, even continuing
damage does not maintain high levels.
In the context of liver disease, measuring both ALT and AST provides
little additional information over that provided by measuring either one.
There are two exceptions: in fatty liver disease, an activity ratio AST/ALT
of >2 suggests alcohol as a cause; a ratio of ≤1 is suggestive of a non‐
alcoholic cause. -
Reference Ranges:
All ages: 0 - 40 U/L
All ages: 0 - 40 U/L
-
Factors Affecting Result:
Haemolysis.
In very rare cases gammopathy, in particular type IgM (Waldenström’s macroglobulinemia), may cause unreliable resultsHaemolysis.
In very rare cases gammopathy, in particular type IgM (Waldenström’s macroglobulinemia), may cause unreliable results -
Other Info:
Plasma- Lithium Heparin also acceptable
Plasma- Lithium Heparin also acceptable
-
Routine Contact Name:
Duty Biochemist
-
Routine Telephone:
Freeman: 0191 244 8889
RVI: 0191 282 9719Freeman: 0191 244 8889
RVI: 0191 282 9719 -
Routine Email: